15th March 2018 - SENSIUM are delighted to announce the appointment of Chad Bateman as CEO. Chad will bring with him a wealth of experience in the commercialisation of novel innovative medical technologies.
Chad has most recently been CEO of INOTEC AMD and has previously held executive roles with Acelity and CR Bard. Chad has been brought into to the company to drive the commercialisation of the Sensium system.
Upon appointment of Chad, Luc Van Schil, CEO of the Surgical Company Group announced:
“With Chad on board, Sensium brings in the vision and the skills to accelerate the adoption of early warning systems in the hospital and homecare environment. EWS addresses a current need to improve patient care. In tracking a deteriorating patient early, we can help to reduce the length of stay in the hospital significantly, without losing control on surveillance”
“I feel privileged to be joining Sensium Healthcare at a time when we see the global health and care environment evolving at a rapid pace. A new and innovative technology such as Sensium, will be a valuable tool in helping clinicians and administrators manage patients and resources more effectively through the early detection of patient deterioration. This will help patients to be treated more quickly, improve quality of life, while reducing capacity burden on the health economies. We have a wonderful group of people at SENSIUM who feel passionate about the Sensium solution and I look forward to working with them as we take this wonderful solution forward.”
Originally from South Africa, Chad has been living and working in the UK for the past 20 years and is now based in Reigate, Surrey, where is with he lives with his wife Karen and 3 sons, Noah, Travis and Caleb.